Relative to Asthma and Allergy Awareness Month.
SCR 172 is a Senate Concurrent Resolution that designates May 2026 as Asthma and Allergy Awareness Month in California. The resolution does not create a regulatory program or require state agencies to take new action; instead, it uses legislative recognition to highlight the prevalence, health impacts, and economic costs of asthma and food allergies, and to encourage public observance through ceremonies and activities.
The measure’s findings emphasize that asthma affects millions of children and adults nationwide and more than 3.15 million Californians, contributes to emergency room visits, hospitalizations, school absences, and deaths, and disproportionately burdens Black, Hispanic, and Indigenous communities. It also notes the growing prevalence of food allergies, especially among children, and the need for affordable insurance, medications, and medical devices. The resolution was chaptered as Resolution Chapter 89, Statutes of 2026, reflecting formal legislative adoption rather than a policy mandate.
Because SCR 172 is a concurrent resolution, its legal effect is limited: it does not amend the Health and Safety Code, Insurance Code, Education Code, or any other statute, and it does not impose enforceable duties or appropriations. Its primary impact is symbolic and commemorative, formally recognizing May 2026 as Asthma and Allergy Awareness Month and encouraging public awareness activities. The resolution may support outreach by health advocates, schools, and community organizations, but it does not directly change benefits, coverage, or treatment requirements for asthma or allergy care.
The available record suggests broad, noncontroversial support for the resolution. The bill was introduced with multiple coauthors from different political perspectives, and there are no committee transcripts or recorded votes indicating opposition or debate. Its findings frame asthma and food allergies as significant public health concerns, which typically makes awareness resolutions politically easy to support. The fact that it was chaptered indicates it advanced successfully through the legislative process.
No notable contention appears in the available materials. Because the measure is an awareness resolution rather than a substantive policy bill, there is no evidence of disagreement over regulatory burdens, fiscal costs, or implementation. The only substantive themes in the text are public health disparities, access to affordable medications and insurance, and the burden of asthma and food allergies on children and families; these are presented as reasons for recognition rather than as disputed policy questions.